Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 5,595.00
-95.00 (-1.67%)
Jul 31, 2025, 5:24 PM IDT
TLV:TEVA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -157 | -1,639 | -559 | -2,446 | 417 | -3,990 | Upgrade |
Depreciation & Amortization | 1,022 | 1,059 | 1,153 | 1,308 | 1,330 | 1,557 | Upgrade |
Loss (Gain) From Sale of Assets | -21 | -22 | -41 | 10 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 1,523 | 2,555 | 1,078 | 2,447 | 594 | 6,626 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | 104 | -213 | Upgrade |
Stock-Based Compensation | 135 | 123 | 121 | 124 | 119 | 129 | Upgrade |
Other Operating Activities | -149 | -394 | -312 | -1,208 | -65 | -705 | Upgrade |
Change in Accounts Receivable | 245 | 245 | 12 | 334 | -574 | -293 | Upgrade |
Change in Inventory | 166 | 166 | -147 | -163 | 380 | 41 | Upgrade |
Change in Accounts Payable | 258 | 258 | 1,588 | 2,012 | 764 | -463 | Upgrade |
Change in Other Net Operating Assets | -1,632 | -1,104 | -1,525 | -828 | -2,271 | -1,473 | Upgrade |
Operating Cash Flow | 1,390 | 1,247 | 1,368 | 1,590 | 798 | 1,216 | Upgrade |
Operating Cash Flow Growth | 19.01% | -8.85% | -13.96% | 99.25% | -34.38% | 62.57% | Upgrade |
Capital Expenditures | -500 | -498 | -526 | -548 | -562 | -578 | Upgrade |
Cash Acquisitions | - | -15 | - | -7 | - | - | Upgrade |
Divestitures | 68 | 43 | 68 | 68 | 311 | 67 | Upgrade |
Investment in Securities | -3 | -31 | -46 | 3 | 125 | -43 | Upgrade |
Other Investing Activities | 5 | 2 | -5 | - | 1 | 12 | Upgrade |
Investing Cash Flow | 907 | 792 | 968 | 656 | 1,523 | 863 | Upgrade |
Short-Term Debt Issued | - | - | 700 | - | 700 | 550 | Upgrade |
Long-Term Debt Issued | - | - | 2,451 | - | 4,974 | - | Upgrade |
Total Debt Issued | 2,305 | - | 3,151 | - | 5,674 | 550 | Upgrade |
Short-Term Debt Repaid | - | - | -700 | - | -700 | -559 | Upgrade |
Long-Term Debt Repaid | - | -1,641 | -4,152 | -1,369 | -7,140 | -1,871 | Upgrade |
Total Debt Repaid | -4,353 | -1,641 | -4,852 | -1,369 | -7,840 | -2,430 | Upgrade |
Net Debt Issued (Repaid) | -2,048 | -1,641 | -1,701 | -1,369 | -2,166 | -1,880 | Upgrade |
Other Financing Activities | -364 | -150 | -212 | -118 | -6 | -5 | Upgrade |
Financing Cash Flow | -2,412 | -1,791 | -1,913 | -1,487 | -2,172 | -1,885 | Upgrade |
Foreign Exchange Rate Adjustments | 19 | -174 | -30 | -123 | -128 | 8 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | -1 | - | - | - | - | Upgrade |
Net Cash Flow | -97 | 73 | 393 | 636 | 21 | 202 | Upgrade |
Free Cash Flow | 890 | 749 | 842 | 1,042 | 236 | 638 | Upgrade |
Free Cash Flow Growth | 31.08% | -11.04% | -19.19% | 341.52% | -63.01% | 186.10% | Upgrade |
Free Cash Flow Margin | 5.35% | 4.53% | 5.31% | 6.98% | 1.49% | 3.83% | Upgrade |
Free Cash Flow Per Share | 0.78 | 0.66 | 0.75 | 0.94 | 0.21 | 0.58 | Upgrade |
Cash Interest Paid | 1,004 | 1,004 | 1,078 | 948 | 913 | 846 | Upgrade |
Cash Income Tax Paid | 471 | 471 | 298 | 543 | 495 | 709 | Upgrade |
Levered Free Cash Flow | 1,604 | 2,622 | 3,294 | 2,900 | 2,307 | 1,764 | Upgrade |
Unlevered Free Cash Flow | 2,214 | 3,249 | 3,938 | 3,481 | 2,863 | 2,327 | Upgrade |
Change in Net Working Capital | 631 | -457 | -1,202 | -933 | -52 | 690 | Upgrade |
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.